Joel Greenblatt's BRKR Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 308,146 shares of Bruker Corporation (BRKR) worth $14.52 M, representing 0.05% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 47 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in BRKR, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 803,474 shares. Largest reduction occurred in Q2 2015, reducing 777,706 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Bruker Corporation (BRKR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bruker Corporation (BRKR) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +49,329 | Add 19.06% | 308,146 | $47.11 |
| Q3 2025 | -304,460 | Reduce 54.05% | 258,817 | $32.49 |
| Q2 2025 | +433,515 | Add 334.08% | 563,277 | $41.20 |
| Q1 2025 | +23,438 | Add 22.04% | 129,762 | $41.74 |
| Q4 2024 | +63,231 | Add 146.73% | 106,324 | $58.62 |
| Q3 2024 | -247 | Reduce 0.57% | 43,093 | $69.06 |
| Q2 2024 | +22,615 | Add 109.12% | 43,340 | $63.81 |
| Q1 2024 | +2,080 | Add 11.16% | 20,725 | $93.94 |
| Q4 2023 | -23,235 | Reduce 55.48% | 18,645 | $73.48 |
| Q3 2023 | +23,353 | Add 126.05% | 41,880 | $62.30 |
| Q2 2023 | +18,527 | New Buy | 18,527 | $73.92 |
| Q1 2023 | -5,465 | Sold Out | 0 | $0.00 |
| Q4 2022 | +1,638 | Add 42.80% | 5,465 | $68.35 |
| Q3 2022 | -8,065 | Reduce 67.82% | 3,827 | $53.04 |
| Q2 2022 | +5,204 | Add 77.81% | 11,892 | $62.73 |
| Q1 2022 | -4,189 | Reduce 38.51% | 6,688 | $64.29 |
| Q4 2021 | +116 | Add 1.08% | 10,877 | $83.94 |
| Q3 2021 | -6,665 | Reduce 38.25% | 10,761 | $78.06 |
| Q2 2021 | +17,426 | New Buy | 17,426 | $75.98 |
| Q4 2020 | -6,829 | Sold Out | 0 | $0.00 |
| Q3 2020 | -7,771 | Reduce 53.23% | 6,829 | $39.68 |
| Q2 2020 | +1,754 | Add 13.65% | 14,600 | $40.68 |
| Q1 2020 | -28 | Reduce 0.22% | 12,846 | $35.89 |
| Q4 2019 | -5,836 | Reduce 31.19% | 12,874 | $50.96 |
| Q3 2019 | -128,146 | Reduce 87.26% | 18,710 | $43.93 |
| Q2 2019 | -13,325 | Reduce 8.32% | 146,856 | $49.95 |
| Q1 2019 | +62,375 | Add 63.77% | 160,181 | $38.44 |
| Q4 2018 | -35,040 | Reduce 26.38% | 97,806 | $29.77 |
| Q3 2018 | +20,322 | Add 18.06% | 132,846 | $33.45 |
| Q2 2018 | +43,779 | Add 63.68% | 112,524 | $29.04 |
| Q1 2018 | +68,745 | New Buy | 68,745 | $29.92 |
| Q3 2017 | -77,652 | Sold Out | 0 | $0.00 |
| Q2 2017 | +28,931 | Add 59.38% | 77,652 | $28.83 |
| Q1 2017 | +35,401 | Add 265.77% | 48,721 | $23.34 |
| Q4 2016 | +13,320 | New Buy | 13,320 | $21.17 |
| Q3 2016 | -251,600 | Sold Out | 0 | $0.00 |
| Q2 2016 | -460,859 | Reduce 64.69% | 251,600 | $22.74 |
| Q1 2016 | +712,459 | New Buy | 712,459 | $28.00 |
| Q3 2015 | -126,102 | Sold Out | 0 | $0.00 |
| Q2 2015 | -777,706 | Reduce 86.05% | 126,102 | $20.41 |
| Q1 2015 | -742,587 | Reduce 45.10% | 903,808 | $18.47 |
| Q4 2014 | +205,879 | Add 14.29% | 1.65 M | $19.62 |
| Q3 2014 | +542,068 | Add 60.33% | 1.44 M | $18.51 |
| Q2 2014 | +803,474 | Add 845.99% | 898,448 | $24.27 |
| Q1 2014 | +94,974 | New Buy | 94,974 | $22.79 |
| Q3 2013 | -33,522 | Sold Out | 0 | $0.00 |
| Q2 2013 | +33,522 | Add 0.00% | 33,522 | $16.14 |
Joel Greenblatt's Bruker Corporation Investment FAQs
Joel Greenblatt first purchased Bruker Corporation (BRKR) in Q2 2013, acquiring 33,522 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Bruker Corporation (BRKR) for 47 quarters since Q2 2013.
Joel Greenblatt's largest addition to Bruker Corporation (BRKR) was in Q2 2014, adding 898,448 shares worth $21.8 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 308,146 shares of Bruker Corporation (BRKR), valued at approximately $14.52 M.
As of the Q4 2025 filing, Bruker Corporation (BRKR) represents approximately 0.05% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Bruker Corporation (BRKR) was 1,646,395 shares, as reported at the end of Q4 2014.